CA
ANVS icon

Cetera Advisors’s Annovis Bio ANVS Stock Holding History

Cetera Advisors’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$122K Buy
+10,225
New +$112K ﹤0.01% 2288

Other funds holding ANVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WFAG
Wescott Financial Advisory Group Philadelphia, Pennsylvania $1.14B AUM 16.59% 1-Year Est. Return
RAM
Redmond Asset Management Henrico, Virginia $366M AUM 10.64% 1-Year Est. Return
SIAP
Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $552M AUM 26% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
MWM
Modera Wealth Management Westwood, New Jersey $8.34B AUM 19.68% 1-Year Est. Return

Cetera Advisors's ANVS Position: Q1 2024 in Review

Cetera Advisors opened a new position in Annovis Bio (ANVS) in Q1 2024: 10,225 shares worth $122K. The stake represents ﹤0.01% of the portfolio and ranks #2288 among its holdings.

32 funds tracked by Wall St. Rank hold ANVS as of Q1 2024.

  • Cetera Advisors held 10,225 shares of Annovis Bio worth $122K as of Q1 2024.
  • Annovis Bio was a new Cetera Advisors position in Q1 2024.
  • Annovis Bio made up ﹤0.01% of Cetera Advisors's portfolio in Q1 2024, its #2288 holding.
  • 32 funds tracked by Wall St. Rank held Annovis Bio as of Q1 2024.

Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.